Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Neal Gupta und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Dermatologic Agents, Inflammatory Bowel Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gupta, N., Ray, M., Shayya, A., McGinnis, S., Marson, J., & Jagdeo, J. (2025). Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9168
Vancouver
Gupta N, Ray M, Shayya A, McGinnis S, Marson J, Jagdeo J. Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9168
BibTeX
@article{Gupta2025,
author = {Gupta, Neal and Ray, Maile and Shayya, Ashley and McGinnis, Sandra and Marson, Justin and Jagdeo, Jared},
title = {Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9168}
}
EUVIMED